Start the conversation
Comment on This Story
Or to contact Money Morning Customer Service, click here.
This site uses Akismet to reduce spam. Learn how your comment data is processed.
At the end of 2018, the Federal Reserve told the market the water was warm, come in for a swim.
The market was happy to oblige. In fact, the S&P 500 has rebounded almost 11% to start 2019, nearly erasing all of the losses from December.
It's as if the sell-off never happened.
Never mind slowing GDP growth, and never mind an earnings recession.
These are temporary problems that investors can look past, knowing the central bank is firmly ensconced on the sidelines.
But going forward, it's fair for investors to wonder if all the easy money has already been made.
Don't worry. Right now, this market is a stock picker's dream.
Accelerate Your Gains: Stocks will make you money, but trading can set you up for life. With the secrets in this video series, you could potentially start collecting anywhere from $1,190, $1,313, and even $2,830 in consistent income – each and every week. See for yourself…
The major indexes will likely face major resistance going forward, but certain individual stocks are poised for big gains.
But how do you determine which stocks are poised for market-beating returns this year?
The Money Morning Stock VQScore™ system has the answer.
In fact, in just the last two weeks, certain biotech stocks identified by the VQScore have outperformed the market by three or four times.
I wrote about those stocks here.
While the S&P 500 is up around 1% since that article was published, two of the three stocks mentioned are up almost 5%.
The run for biotech stocks has just begun, and not only for the three stocks I previously showed you.
The VQScore has found two more biotech stocks that just received our highest rating.
Here are the details on these two biotech stocks to buy now…
I am interested in learning more about biotech.